Article

Vision quality is patients' top priority when choosing products

Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

Rochester, NY-Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

The NSIGHT study, commissioned by Bausch + Lomb and conducted by Market Probe: Europe, an independent market research firm, surveyed 3,800 spectacle- and contact lens-wearing patients aged 15 to 65 years, from seven countries (China, Korea, Japan, France, Italy, the United Kingdom, and the United States). It aimed to determine a hierarchy of patient needs in the selection of eye-related products, based on respondents’ scoring of 40 features representing eight categories of potential product features.

The study revealed that product benefits relating to vision quality are highly important to patients all around the world. When patients are asked to trade off various functional needs relative to eye-care products, comfort becomes only half as important as vision quality.

The eight categories of eye-care product benefits, in descending order of importance to patients, were vision, health, environment, eye condition, convenience, comfort, personal performance, and personal appearance.

"NSIGHT validated that clear, crisp vision is a top priority for our patients,” said Carla Mack, OD, FAAO, director, global medical affairs, Bausch + Lomb.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.